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Background: Color Doppler ultrasonography (CDUS) has been used for the diagnosis of
diffuse and nodular thyroid diseases as a noninvasive assessment method for the evalu-
ation of blood flow for nearly two decades. The study was undertaken to determine vas-
cularity of the thyroid gland using CDUS and the inferior thyroidal artery (ITA) in the
hypothyroid patients and evaluate their relationship with the efficacy of the medical
treatment for hypothyroidism.
Patients and Methods: A total of 42 patients with hypothyroidism were evaluated clini-
cally by laboratory tests regarding the thyroid function and by CDUS for estimation of the
parenchymal color flow pattern (PCFP) of the thyroid gland and the measurement of the
maximum systolic velocity (MSV) in the ITA both before and after medical treatment for
6 months.
Results: The mean thyroid stimulating hormone (TSH) and MSV values of the ITA which
were noted before and after therapy as 25.7 ± 26.7 μIU/mL, 35.5 ± 10.1 cm/sec and
1.6 ± 0.8 μIU/mL, 31.0 ± 10.2 cm/sec respectively were significantly different (p < 0.001,
p = 0.02, respectively). The PCFP did not change in 29 patients, whereas in 10 patients it
changed to a lower grade and in three patients to a higher grade. By comparison of the
patients without any change in PCFP and those with a change to lower grade, significant
differences for the decrease of TSH and MSV of the ITA were noted (p = 0.035 and
p = 0.027, respectively).
Conclusion: MSV of the ITA, as well as PCFP, can be used to assess the vascularity of 
the thyroid gland in the hypothyroidism. The vascular change of PCFP and decreased
MSV of the ITA after thyroid hormone replacement may have a adjuvant role for deter-
mining the effects of medical treatment in the hypothyroidism in addition to hormonal
evaluation.
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Introduction
Color Doppler ultrasonography (CDUS) has been
used for the diagnosis of diffuse and nodular thyroid
diseases for nearly two decades. It allows non inva-
sive assessment of blood flow being a sign of intra-
parenchymal vascularity as well as the evaluation
of morphology in thyroid imaging. It is well-known
that various thyroid disorders can modify blood
flow of the thyroid gland, which may be assessed
by several invasive methods like angiography, elec-
tromagnetic flowmetry and radionuclide imaging.
Previously, CDUS appearance of a number of thyroid
disorders was described by Fobbe et al [1]. In this
regard the association of certain color characteris-
tics with distinct pathologies were investigated
extensively [2]. Long ago in a pilot study compris-
ing patients with Graves’ disease, Ralls et al [3]
described the characteristic “thyroid inferno” pat-
tern referring to the hypervascularity of the thyroid
gland. The aforementioned pattern was later pro-
posed by several authors as a valuable tool for dif-
ferential diagnosis of diffuse thyroid disease [4–7].
However, the pattern was no longer accepted to be
specific for hyperthyroidism after several authors
reported similar CDUS findings in euthyroid or
hypothyroid patients [7,8].
To the best of our knowledge, only a few studies
concerning CDUS in patients with hypothyroidism
have been reported in the literature [2,7–9]. Simi-
larly, several studies on the spectral Doppler mea-
surement of blood flow in the inferior thyroidal
artery (ITA) have been documented in the English
literature [10–13]. In this study our first goal was
to define CDUS characteristics of the thyroid gland
and ITA in patients with hypothyroidism. Besides,
we aimed to determine whether CDUS of the thy-
roid gland and the measurement of the blood flow
in the ITA, which may additionally be expected to
overcome the limitations of the qualitative paren-
chymal analysis, can be a reliable measure for the
efficacy of the medical treatment and thus improve
the sensitivity of ultrasound (US) for the monitor-
ization of the adequacy of the treatment for
hypothyroidism.
Patients and Methods
The study group comprised a total of 42 female
patients with hypothyroidism, aged from 20 to 51
(mean, 34.7) who were outpatients from Depart-
ment of Endocrinology at Ankara Training and
Research Hospital, Ankara, Turkey. They were all
Hashimoto’s thyroiditis cases, the diagnosis of
whom were confirmed citologically and by hor-
monal and auto-antibodies analysis. Hypothyroidism
after a thyroidectomy or radioiodine therapy as well
as the presence of distinguishable thyroid nodules
were accepted as exclusion criteria. The initial eval-
uation of the patients was performed clinically, by
laboratory tests regarding the thyroid function,
and by gray-scale US and CDUS. In each patient 
a complete clinical history was taken followed by
the clinical examination of the thyroid gland. Serum
concentrations of free thyroxine (FT4), triiodothy-
ronine (T3), thyroid stimulating hormone (TSH) and
titers of antibodies to thyroglobulin (anti-TG Ab)
and thyroid peroxidase (anti-TPO Ab) were deter-
mined using commercial kits. Normal values for
the aforementioned laboratory variables were as
follows: FT3 (1.6–4.9 pg/mL), FT4 (0.7–2.1 ng/mL),
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anti-TG Ab (10–100 UI/mL), anti-TPO Ab (1–10 UI/
mL), and TSH (0.4–4.0 μIU/mL).
In each US examination which was carried out
by the same radiologist (A.T.T), who was unaware
of the laboratory values, a CDUS scanner (Shimadzu,
SDU-2200, Japan) equipped with a 5–10 MHz linear
transducer was used. By US examination in gray
scale, parenchymal echotexture of the gland was
evaluated. Furthermore, the volume of each lobe 
was calculated automatically by the US machine by
means of the elipsoid formula:
Volume of thyroid lobe = 0.52 × mld × apd × ccd
where mld, apd and ccd represent the transverse,
anteroposterior and craniocaudal diameters of the
thyroid lobe respectively. The total glandular volume
was calculated by adding the volumes of the two
lobes and the volume of the isthmus, which repre-
sents a negligible part of the gland’s volume was
not taken into consideration. On the other hand,
during the CDUS examination pre-set values usu-
ally used for the examination of the carotid arteries
by which the normal thyroid gland shows no or
only very sparse vascularization accompanied with
prominent ITA were used. The parenchymal color
flow pattern (PCFP) within the thyroid gland was
graded according to the subjective criteria described
previously by many authors (Fig. 1) (PCFP 0, blood
flow limited to the peripheral thyroid arteries and
parenchymal flow absent; PCFP 1, mildly increased
parenchymal blood flow with patchy uneven dis-
tribution; PCFP 2, obviously increased color flow
with patchy distribution; and PCFP 3, prominently
increased color flow homogenous in distribution,
also called as “thyroid inferno”) [2,4,8]. Pulsed
Doppler studies were performed whereby the mea-
surement of three consecutive systolic and diastolic
maximum flow velocities in the ITA were followed
by the calculation of a mean value. The studies were
performed by transverse scanning of ITA where the
vessel had a transverse course crossing the main
branch of the carotid posteriorly, or in longitudinal
scanning of the ascending tract of the artery, at the
region where it lies parallel to the common carotid
artery (Fig. 2). Then, the mean of the calculated
maximum systolic velocity (MSV) values for both
ITA were noted.
The patients were reevaluated 6 months after
the beginning of medical treatment for hypothy-
roidism by which time the hormonal status for all
of the patients had been shown to return to normal
during the preceding monthly visits. The medical
therapy comprised the application of L-thyroxine
with an initial 50 mcg (μg) daily dose, which was
changed if necessary in regard to the monthly
monitorization of blood TSH levels.
All patients included to the study gave informed
consent prior to US examinations and the study
protocol was approved by the local institutional
training board (ethical committee). Statistical analy-
ses were performed with commercially available
BA
Fig. 1. The qualitative analysis of the change of the PCFP 2 to PCFP 0 during the initial evaluation (A) and after undergoing 
a medical therapy for a duration of 6 months (B).
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software, SPSS for Windows (version 7.5). When the
Kolmogorov-Smirnov test revealed normal distribu-
tion for the values of any parameter, the statistical
analysis of the differences between groups was per-
formed by the one-way analysis of variance (ANOVA)
and the comparison of the pre- and post-treatment
values was performed by paired sample t test.
When the Kolmogorov-Smirnov test revealed non-
homogenous distribution for the values of any
parameter, the statistical analysis of the differences
between groups was performed by Kruskal-Wallis
and Mann-Whitney U tests and the comparison of
the pre and post-treatment values was performed
by Wilcoxon paired two samples test. Correlations
between the values of the parameters were investi-
gated by Pearson’s or Spearman’s correlation. A value
of p < 0.05 was considered statistically significant.
Results
Descriptive statistics for the patients within the study
group both during the initial evaluation and after
the medical treatment for a duration of 6 months are
shown in Tables 1 and 2. PCFP and MSV in the ITA
in relation to laboratory and clinical variables dur-
ing the initial evaluation and following the medical
treatment of the patients with hypothyroidism are
shown in Tables 3 and 4. The mean duration of
hypothyroidism at the time of initial examination
was 10.6 months (range, 1–60 months). During the
initial evaluation the thyroid glands of all patients
were hypoechoic of varying degree, frequently
patchy in distribution ultrasonographically. Within
the whole group of eight patients 42 hypothyroid
patients had PCFP 0, mean MSV of 23.4 cm/sec,
A B
Fig. 2. Blood flow measurement in the ITA during the initial evaluation (A) and after undergoing a medical therapy for hypo-
thyroidism for a duration of 6 months (B) which depicts the decrease of the maximum systolic velocity from 42.7 cm/sec to
31.9 cm/sec.
Table 1. Descriptive statistics for the patients within the study group during the initial evaluation
N Mean SD Minimum Maximum
Age 42 34.7 8.5 20 51
FT3 (1.6–4.9 pg/mL) 42 2.50 0.66 0.59 3.85
FT4 (0.7–2.1 ng/mL) 42 0.93 0.30 0.26 1.98
TSH (0.4–4.0 μIU/mL) 42 25.67 26.73 6.85 100.00
Anti-TG Ab (10–100 UI/mL) 42 1,064.3 1,437.1 17 6,724
Anti-TPO Ab (1–10 UI/mL) 42 348 303 9.32 1,365
Volume (mL) 42 14.6 8.0 2.0 38.6
Mean MSV (cm/sec) 42 35.5 10.2 17 58
N = number of patients; SD = standard deviation; MSV = maximum systolic velocity.
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and TSH of 21.6μIU/mL. Nevertheless, in 34 patients
(81%) different degrees of increased parenchymal
vascularization and MSV were detected (22 patients
with PCFP 1, MSV:35.8 cm/sec, and TSH:21.8 μIU/
mL; nine patients with PCFP 2, MSV:44.9 cm/sec,
and TSH:20.0 μIU/mL; and three patients with
PCFP 3, MSV:37.7 cm/sec, and TSH:82.5 μIU/mL).
In regard to the PCFP, significant differences for
TSH, glandular volume and MSV were detected (p =
0.047, p = 0.007 and p < 0.001, respectively). By sta-
tistical analysis significant differences were detected
by the comparison of each of the subgroups with
PCFP 1, 2 and 3 and that with PCFP 0 for mean MSV
(p < 0.001, p < 0.001 and p = 0.014, respectively). In
a similar fashion each of the subgroups with PCFP
0, 1 and 2 were found to be significantly different
from that with PCFP 3 for mean TSH (p = 0.024,
p=0.015, and p=0.012, respectively). In terms of the
glandular volume significant differences were de-
tected between subgroups with PCFP 0 and 2 and
PCFP 1 and 2 (p = 0.003 and p = 0.006, respectively).
Additionally subgroups with PCFP 1 and 2 were
significantly different from each other in terms of
anti-TPO Ab (p = 0.016).
The number of patients with PCFP 0, 1, 2 and 3
after the therapy were 10, 23, 9 and 0. Statistically,
mean TSH and MSV values of the ITA which were
noted before and after therapy as 25.7 ± 26.7 μIU/
mL, 35.5 ± 10.1cm/sec and 1.6 ± 0.8 μIU/mL, 31.0 ±
10.2 cm/sec respectively were found to be signifi-
cantly different from each other (p < 0.001, p = 0.02,
respectively). Although no change for PCFP was pres-
ent in 29 patients, a change to a lower grade was
detected in 10 patients (Fig. 1), whereas the change
Table 2. Descriptive statistics for the patients within the study group after medical treatment for hypothyroidism
for a duration of 6 months
N Mean SD Minimum Maximum
Age 42 34.7 8.5 20 51
FT3 (1.6–4.9 pg/mL) 42 3.21 0.59 2.12 5.10
FT4 (0.7–2.1 ng/mL) 42 1.36 0.34 0.78 2.10
TSH (0.4–4.0 μIU/mL) 42 1.60 0.84 0.10 2.94
Anti-TG Ab (10–100 UI/mL) 42 776 977.9 26 4,000
Anti-TPO Ab (1–10 UI/mL) 42 292.5 302.8 9 1,365
Volume (mL) 42 14.3 7.4 3.6 36.4
Mean MSV (cm/sec) 42 31.0 10.0 17 63
N = number of patients; SD = standard deviation; MSV = maximum systolic velocity.
Table 3. Parenchymal color flow pattern and maximum systolic flow velocity in the inferior thyroidal artery in
relation to laboratory and clinical variables during the initial evaluation of the patients with hypothyroidism
Color flow pattern 0 1 2 3
Number of patients 8 22 9 3
FT3 (1.6–4.9 pg/mL) 2.36 2.60 2.43 2.30
FT4 (0.7–2.1 ng/mL) 0.89 0.93 0.91 1.10
Anti-TG Ab (10–100 UI/mL) 1,573 946 715 1,624
Anti-TPO Ab (1–10 UI/mL) 474 237 499 379
TSH (0.4–4.0 μIU/mL) 21.6 21.8 20.0 82.5
Volume (mL) 9.9 13.5 22.9 11.2
Mean MSV (cm/sec) 23.4 35.8 44.9 37.7
MSV = maximum systolic velocity.
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was to a higher grade in three patients. By compar-
ison of the patients without any change in PCFP
and those with a change to lower grade for the dif-
ferences in the values of the study parameters, sig-
nificant differences for the decrease of TSH and
MSV of the ITA were noted (p = 0.035 and p = 0.027,
respectively) (Fig. 2). The comparison of the patients
without any change in PCFP and those with a
change to a higher grade in terms of the differences
for mean MSV values revealed a significant differ-
ence (p = 0.006). Besides a significant statistical dif-
ference was detected for the amount of decrease
in the level of anti-TPO Ab by the comparison of
the same subgroups (p = 0.03). Similarly, by com-
parison of the patients with a change in PCFP to 
a lower grade and those with a change to higher
grade, significant differences were detected for the
differences of MSV of the ITA and anti-TPO Ab
level (p = 0.014 and p = 0.017, for each). The mean
TSH and MSV values in the study group were
found to decrease significantly after the medical
treatment (p < 0.001, p = 0.002, respectively). Addi-
tionally, mean levels of anti-TPO Ab and thyroid
glandular volume in the study group decreased after
the medical treatment, though the difference was
not significant statistically (p > 0.05, respectively).
Positive correlations were calculated between the
PCFP determined by the initial US evaluation and
the values for TSH (r = 0.357, p = 0.020), glandular
volume (r = 0.336, p = 0.030) and MSV of the ITA
(r = 0.566, p < 0.001) detected during the same
evaluation.
Discussion
The value of CDUS in thyroid diseases has still been
debated on because of the unequivocal results re-
ported. In several studies, it has been shown that
CDUS pattern of intense hypervascularization of
the thyroid gland, which was formerly attributed
only to the hyperthyroid state in active Graves’ dis-
ease can also be seen in hypothyroidism [2,8–10].
Although these studies have some variations regard-
ing the methodology, the authors commonly agree
that a diffuse hypervascular pattern, in contrast with
the previous reports [3–5], is no longer unique for
Graves’ disease and it can be detected in patients
with Hashimoto’s autoimmune thyroiditis as well.
In 2003, one report indicated a significantly
increased vascularization of the thyroid gland in
hypothyroid patients with higher antibody titres
(thyroglobulin and thyroid peroxidase antibodies)
[2]. Accordingly, the authors attributed the finding
to a possible correlation with immunoreactivity
[2]. In addition, the authors noted that the afore-
mentioned vascularization may be affected by fac-
tors like thyroid volume, iodine intake and TSH [2].
In a previous study by Iitaka et al [14], it was con-
cluded that vascular endothelial growth factor may
Table 4. Parenchymal color flow pattern and maximum systolic flow velocity in the inferior thyroidal artery in
relation to laboratory and clinical variables in each subgroup of patients in regard to the parenchymal color
flow patterns after the medical treatment for hypothyroidism for a duration of 6 months
Color flow pattern 0 1 2
Number of patients 10 23 9
FT3 (1.6–4.9 pg/mL) 3.20 3.22 3.21
FT4 (0.7–2.1 ng/mL) 1.34 1.39 1.29
Anti-TG Ab (10–100 UI/mL) 803 779 743
Anti-TPO Ab (1–10 UI/mL) 327 271 309
TSH (0.4–4.0 μIU/mL) 1.44 1.64 1.68
Volume (mL) 8.92 16.00 15.75
Mean MSV (cm/sec) 24.4 31.0 38.4
MSV = maximum systolic velocity.
activate thyroideal angiogenesis in patients with
Graves’ disease and Hashimoto’s thyroiditis only if
the levels of TSH and TSH receptor antibody (TRAb)
are increased as well. In another study by Bogazzi
et al [9], hypervascularity seen in the aforemen-
tioned thyroideal pathologies would be attributed
to the activation of TSH-receptor by TRAb or by thy-
rotropin. Very recently, Corona et al [12] reported
that CXCL10 chemokine would have an important
role in intrathyroid angiogenesis modulation asso-
ciated with CDUS findings typical of thyroid
autoimmune diseases.
Our finding regarding CDUS pattern of intense
hypervascularization is in accordance with few pre-
vious studies focusing on the same topic. During
the initial CDUS evaluation of the patients included
to the present study, the vast majority of the cases
with hypothyroidism (81%, 34/42) had diffuse
hypervascularization of varying degrees, including
three cases with markedly increased hypervascu-
larization termed as “thyroid inferno”. It is evident
that this picture is not associated with excess serum
levels of thyroid hormone. Importantly, the initial
grade for PCFP was found to have a positive corre-
lation with TSH and glandular volume determined
during the initial evaluation. In this regard, our
findings suggest that thyroid stimulation mainly
by TSH is responsible for the increased flow.
Recently, Baldini et al [15] noted that thyroid
vascularization by CDUS would be closely associ-
ated with Graves disease activity. In 2001, Wang 
et al [16] reported that resistive index can be used
for the determination of the need for ablative or
antithyroid drug therapy in patients with Graves’
disease. The quantitative assessment of the blood
flow of the thyroid gland can also be performed by
the measurement of MSV in the afferent arteries 
of the thyroid, namely superior and inferior thy-
roid arteries [12,17,18]. In surgical practice, the
method enables the operator to avoid the inherent
disadvantage of subjectivity of qualitative parenchy-
mal blood flow assessment. Our findings revealed
that a statistically significant difference was detected
between the subgroups of patients with different
parenchymal color flow patterns for the mean values
of MSV in ITA. Moreover, a positive correlation was
calculated between the grade for PCFP and MSV of
ITA determined during the intial sonographic eval-
uation, similar to the findings reported by Corona
et al [12]. Therefore, we think that MSV of the ITA,
as well as PCFP, can be accepted as a reliable mea-
sure of the increased vascularity in patients with
hypothyroidism.
In particular, CDUS is also useful for the follow-
up of thyroid diseases. In this regard, the effective-
ness of medical treatment may be monitored reliably
with the gradual decrease of intraparenchymal vas-
cularization [5,8,9]. Nevertheless, improvements
in clinical and laboratory parameters regarding the
functional status of the thyroid always precede the
changes in parenchymal vascularization [19,20]. 
In a previous study, Caruso et al [10] emphasized
that spectral Doppler measurements in ITA demon-
strated the efficacy of medical treatment in Graves’
disease more reliably and earlier than the assess-
ment of PCFP by CDUS. The authors concluded that
the aforementioned measurements may be useful
for the differential diagnosis of diffuse autoimmune
thyroid diseases and in the follow-up of patients
being treated for the Graves’ disease. In the same
study, however, it was also noted that normaliza-
tion of the PCFP occurred in some patients with
subclinical hypothyroidism with diffuse hypervas-
cularity of the thyroid gland, though no significant
change in the flow velocity in ITA was detected in
the same group of patients.
Contrary to the aforementioned study by Caruso
et al [10], however, we found that MSV values 
in ITA in patients with hypothyroidism, together
with TSH values, decreased significantly after treat-
ment. Moreover, we detected that PCFP in one
third of our patients (24%, 10/42) changed to a
lower grade and significant differences were de-
tected between these patients and those without 
a change of PCFP for the mean TSH values and
MSV of ITA. In this regard, we think that the
decrease in the MSV of the ITA, in parallel with the
changes in the levels of the clinical and laboratory
variables, may reflect the efficacy of the medical
treatment in hypothyroidism.
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Importantly, laboratory investigations of thy-
roid function and autoantibodies have still been
accepted as the decisive factors for the diagnosis
and follow-up of the patients with autoimmune
thyroid disease. However, the assessment of PCFP
and blood flow measurement of the ITA by color
and spectral Doppler analysis could have a clinical
role in the initial evaluation of the patients having
clinical findings and laboratory values suggesting
hypothyroidism due to autoimmune thyroid dis-
ease. In addition, we propose the inclusion of the
aforementioned analysis to the follow-up protocol
of the thyroid gland of the patients having treat-
ment for hypothyroidism. Future research on larger
groups will be helpful to elucidate the potential of
CDUS for the pre- and post-treatment evaluation
of patients with hypothyroidism.
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